Michael Atkins, MD | Authors


Dr. Michael Atkins on Benefits of Adjuvant Treatment in Melanoma

March 17, 2016

Atkins says because treatments currently used in patients with visible metastatic melanoma are normally efficacious between 50% and 60% of the time, then the expectation for these treatments in the adjuvant setting could be effective around 80% of the time.